
Target Identification in Prostate Cancer
Limited therapeutic efficacy and drug resistance in advanced-stage prostate cancer contributes to poor outcomes, highlighting the need for targeted therapies with alternative mechanisms of action. Here, we leveraged human-centric AI to accelerate target identification for prostrate adenocarcinoma.

November 27, 2023

Save Time, Reduce Bias, Make Better Decisions
With almost half a million papers on obesity in PubMed, and 2 papers added per minute, identifying promising therapeutic targets is time-consuming, subject to bias and is not always comprehensive. Causaly extracts insights rather than papers, uncovering over 5,000 targets for obesity in seconds.

November 15, 2023

Streamlining Target Identification: A Diabetes Use Case
The rising prevalence of T1D demands new treatments. The identification and understanding of targets for T1D for developing effective drugs and alleviating patient burdens. AI can streamline this process by dramatically reducing reading time, minimizing bias and uncovering hidden target-disease insights, enabling the exploration of more promising avenues.

November 13, 2023